Lung cancer other diagnostic studies

Lung cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lung cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lung cancer other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lung cancer other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lung cancer other diagnostic studies
CDC on Lung cancer other diagnostic studies
Lung cancer other diagnostic studies in the news
Blogs on Lung cancer other diagnostic studies
Directions to Hospitals Treating Lung cancer
Risk calculators and risk factors for Lung cancer other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

Overview

Other diagnostic tests include bone scintigraphy, PET scan, and molecular tests.

Lung Cancer Other Diagnostic Studies

Bone Scintigraphy

A bone scan may demonstrate bone metastases.

PET scan

PET scanning using fluoro-18-2-deoxyglucose (FDG) evaluates solitary pulmonary nodules.

Molecular Test

Molecular tests include epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) mutation. Specific targeted agents may be administered to patients if these mutations are present.